A illustrative representation of the antibiotic resistance, its introduction, cause, mechanism, examples and possible solutions of the antibiotic resistance. with pictorial illustrations for better understanding.
This document presents information on antimicrobial resistance (AMR). It defines AMR as microorganisms becoming resistant to antimicrobial drugs like antibiotics, antivirals, and antimalarials. The document discusses factors that contribute to AMR, including overuse of antibiotics. It describes mechanisms of resistance such as mutations, plasmids, and enzymes that inactivate drugs. It recommends strategies to control AMR like prudent antibiotic use, developing new drugs, and reducing unnecessary use in animals. The conclusion emphasizes that AMR is a global threat that requires strategies to prevent further resistance development.
This document discusses antibiotic resistance, including the discovery of penicillin, sources and classifications of antibiotics, and how antibiotic resistance develops. It notes that antibiotic resistance was first observed in military hospitals where antibiotics were widely used. Bacteria can develop resistance through genetic mutations and plasmids, decreasing drug concentration through efflux pumps, or producing drug-inactivating enzymes. The overuse and misuse of antibiotics contributes to the spread of resistant infections, which can be difficult or impossible to treat.
The document summarizes a presentation on antimicrobial drug resistance given by Dr. Manas Kr. Nath. It discusses the objectives of the presentation, which were to introduce antimicrobial drug resistance, define it, discuss its timeline and factors, mechanisms of resistance, control strategies, and conclusions. The presentation covered intrinsic and acquired resistance, genetic and biochemical mechanisms of resistance such as mutations, plasmids, conjugation, transduction, transformation, transposons, integrons, and production of antibiotic inactivating enzymes. It emphasized that antimicrobial resistance is a major global health concern.
This presentation discusses antibiotic resistance. It defines antibiotics as substances produced by microorganisms that inhibit or kill other microorganisms at low concentrations without harming the host. Antibiotic resistance occurs when bacteria no longer respond to an antibiotic. Mechanisms of resistance include preventing antibiotic access, modifying antibiotics, altering antibiotic target sites, and pumping antibiotics out of cells. Causes of increasing resistance include overprescription, patient noncompliance, overuse in animals, poor drug quality, and lack of sanitation. Solutions proposed are only using antibiotics as prescribed, not sharing or saving antibiotics, and increasing education on resistance.
Antibiotics Resistance is a new issue in Microbiology-Medicine aspects, taken from Lange Review of Medical Microbiology, this purpose is for education only
Antibiotic resistance occurs when bacteria change in response to antibiotic use, making infections harder to treat. Bacteria, not humans or animals, become resistant. This leads to higher medical costs, prolonged hospital stays, and increased deaths. Antibiotic resistance threatens global health and can affect anyone, of any age, in any country. It occurs naturally but also because of misuse of antibiotics in humans and farm animals. This is making many infections like pneumonia, tuberculosis, and gonorrhea more difficult to treat.
This document presents information on antimicrobial resistance (AMR). It defines AMR as microorganisms becoming resistant to antimicrobial drugs like antibiotics, antivirals, and antimalarials. The document discusses factors that contribute to AMR, including overuse of antibiotics. It describes mechanisms of resistance such as mutations, plasmids, and enzymes that inactivate drugs. It recommends strategies to control AMR like prudent antibiotic use, developing new drugs, and reducing unnecessary use in animals. The conclusion emphasizes that AMR is a global threat that requires strategies to prevent further resistance development.
This document discusses antibiotic resistance, including the discovery of penicillin, sources and classifications of antibiotics, and how antibiotic resistance develops. It notes that antibiotic resistance was first observed in military hospitals where antibiotics were widely used. Bacteria can develop resistance through genetic mutations and plasmids, decreasing drug concentration through efflux pumps, or producing drug-inactivating enzymes. The overuse and misuse of antibiotics contributes to the spread of resistant infections, which can be difficult or impossible to treat.
The document summarizes a presentation on antimicrobial drug resistance given by Dr. Manas Kr. Nath. It discusses the objectives of the presentation, which were to introduce antimicrobial drug resistance, define it, discuss its timeline and factors, mechanisms of resistance, control strategies, and conclusions. The presentation covered intrinsic and acquired resistance, genetic and biochemical mechanisms of resistance such as mutations, plasmids, conjugation, transduction, transformation, transposons, integrons, and production of antibiotic inactivating enzymes. It emphasized that antimicrobial resistance is a major global health concern.
This presentation discusses antibiotic resistance. It defines antibiotics as substances produced by microorganisms that inhibit or kill other microorganisms at low concentrations without harming the host. Antibiotic resistance occurs when bacteria no longer respond to an antibiotic. Mechanisms of resistance include preventing antibiotic access, modifying antibiotics, altering antibiotic target sites, and pumping antibiotics out of cells. Causes of increasing resistance include overprescription, patient noncompliance, overuse in animals, poor drug quality, and lack of sanitation. Solutions proposed are only using antibiotics as prescribed, not sharing or saving antibiotics, and increasing education on resistance.
Antibiotics Resistance is a new issue in Microbiology-Medicine aspects, taken from Lange Review of Medical Microbiology, this purpose is for education only
Antibiotic resistance occurs when bacteria change in response to antibiotic use, making infections harder to treat. Bacteria, not humans or animals, become resistant. This leads to higher medical costs, prolonged hospital stays, and increased deaths. Antibiotic resistance threatens global health and can affect anyone, of any age, in any country. It occurs naturally but also because of misuse of antibiotics in humans and farm animals. This is making many infections like pneumonia, tuberculosis, and gonorrhea more difficult to treat.
This document discusses antibiotic resistance and its mechanisms. It defines antibiotic resistance as bacteria developing the ability to resist antibiotics and continue growing. Resistance can be intrinsic or acquired. Intrinsic resistance is natural to the bacteria through impermeability, efflux pumps, biofilms, or enzymatic inactivation. Acquired resistance develops from mutations during antibiotic exposure or gene transfer, allowing target modification, new targets, or enzymatic inactivation. The document examines specific resistance mechanisms and notes the need to slow resistance by completing antibiotic treatments.
Antimicrobial resistance occurs when microorganisms develop the ability to defeat the drugs designed to treat them. There are natural and acquired forms of resistance. Natural resistance involves mechanisms like preventing drug entry or pumping it out, while acquired resistance occurs through mutation or horizontal gene transfer of resistance genes. These resistance genes can spread between bacteria through mobile genetic elements like plasmids, transforming many strains. As resistant bacteria infect more people, standard treatments become ineffective, necessitating new prevention and treatment approaches like bacteriophage therapy.
Antibiotic resistance occurs when bacteria evolve and adapt to antibiotics, making the drugs less effective at killing the bacteria. Many factors can contribute to the rise and spread of antibiotic resistance, including improper use of antibiotics in humans, agriculture, hospitals, and the environment. To address this growing problem, guidelines for antibiotic prescription and public awareness of appropriate antibiotic use need to be improved. Surveillance of antibiotic resistance patterns and infection control practices are also important for monitoring and containing the spread of resistant bacteria.
This document summarizes a seminar on antimicrobial resistance in Nepal. It discusses how antimicrobial resistance is a major public health issue as it can render treatments ineffective and allow infections to spread. It provides examples of resistant bacteria like MRSA. It then covers factors contributing to resistance like overuse of antibiotics in humans, animals, and the environment. The challenges of resistance in Nepal are outlined, such as poverty and lack of awareness. Finally, it proposes mitigation strategies including only using antibiotics when prescribed, reducing unnecessary use in animals, and addressing the issue in Nepal's public health system.
This document discusses antimicrobial resistance mechanisms. It covers natural resistance, acquired resistance, and various resistance mechanisms including biochemical mechanisms like reduced drug entry, efflux pumps, and drug inactivation. It also discusses mutation, gene transfer through transduction, transformation and conjugation, cross resistance, and strategies for preventing drug resistance like prudent antimicrobial use and combination therapy.
This document discusses antimicrobial resistance in Libya. It finds resistance is a serious problem that is increasing, including emerging resistance to newer drugs. Many bacteria isolated from clinical and other sources in Libya show high resistance percentages to various antibiotics. Resistance appears related to easy over-the-counter antibiotic access without prescription, improper hospital usage, and uncontrolled animal antibiotic use. Urgent action is needed to regulate antibiotic sales and usage, educate on proper clinical use, control hospital infections, and regulate non-human antibiotic use to address this growing resistance issue in Libya.
1) Antibacterial agents, also known as antibiotics, are used to inhibit bacterial growth or kill bacteria. They are commonly classified based on their chemical origin or biological effect.
2) Antibacterial agents work by targeting differences between bacterial and animal cells, interfering with bacterial cell wall synthesis, protein synthesis, nucleic acid synthesis, or folic acid synthesis.
3) Common mechanisms of resistance include enzymatic modification of the antibacterial agent, mutations that prevent binding, or active efflux of the agent from the bacterial cell.
This document provides an overview of antimicrobials (also known as antibiotics). It defines antimicrobials and discusses their classification as bactericidal or bacteriostatic. The document outlines the history of antimicrobial discovery and discusses their sources, selective toxicity, and modes of action. Key topics covered include the classification of antibiotics based on chemical structure and mechanism of action, as well as details on specific classes of antibiotics like penicillins, cephalosporins, carbapenems, and others.
This document discusses antimicrobial resistance, including its definition, causes, mechanisms, and impact. It notes that resistance arises naturally but is accelerated by misuse and overuse of antimicrobials in both humans and animals. Resistance occurs via several mechanisms including inactivating drugs, modifying drug targets in bacteria, exporting drugs from bacteria, reducing drug permeability, and mutating genes involved in drug mechanisms of action. It highlights several important antibiotic-resistant bacteria like MRSA, VRE, and multi-drug resistant TB. The global spread of resistance poses a major threat to modern medicine.
A 41-year-old woman with aplastic anemia was admitted with fever. Blood cultures grew E. coli resistant to ampicillin and narrow-spectrum cephalosporins. Despite treatment with multiple antimicrobials over 4 weeks, the patient's fever and bacteremia persisted. The microbiology lab was contacted to help determine why standard therapies were failing to clear the infection.
This document discusses antibiotic resistance mechanisms. It defines antimicrobial resistance (AMR) as when microbes become insensitive to medicines, making infections harder to treat. AMR occurs through two main mechanisms: acquired resistance, where bacteria gain resistance genes, usually through overuse of antibiotics creating selective pressure; and intrinsic resistance, where bacteria innately resist certain drug classes. Bacteria develop resistance via decreased permeability, efflux pumps, enzymatic inactivation of drugs like beta-lactamases, and modifying drug targets. Resistance can be transmitted between bacteria through mutation or mobile genetic elements like plasmids.
There are four main mechanisms by which bacteria become resistant to antibiotics: enzyme production, modified drug targets, decreased permeability, and multidrug resistance pumps. Resistance can be chromosome-mediated via mutations or plasmid-mediated via horizontal gene transfer, with plasmids frequently conferring resistance to multiple drugs. Overuse and misuse of antibiotics, both in medicine and agriculture, places strong selective pressure that drives the emergence and spread of resistant bacteria.
Mechanistic View of Antibiotic Resistance
1. Antibiotic resistance occurs when bacteria no longer respond to antibiotics designed to kill them, allowing them to continue growing. 2. Resistance can be intrinsic, through natural mechanisms like efflux pumps, or acquired through genetic mutations or transfer of genes. 3. Acquired resistance is a concern as it can lead to treatment failure, increased mortality, and spread in communities.
Drug resistance has increased significantly over the past decades as various resistance mechanisms have emerged and spread globally. The document discusses the history of drug resistance beginning with penicillin in the 1940s and the subsequent emergence of resistance to various classes of antibiotics. It describes several factors that have led to increased resistance such as inappropriate antibiotic use in medicine, agriculture, and genetically modified crops. Common resistance mechanisms involve production of antibiotic-modifying enzymes like beta-lactamases, altered antibiotic targets, decreased antibiotic permeability, and active efflux of antibiotics. Detection methods for various resistance enzymes and phenotypes like ESBLs and AmpC beta-lactamases are also summarized.
This document discusses antimicrobial resistance and provides definitions, history, and mechanisms. It defines antimicrobial resistance as the ability of microorganisms like bacteria, viruses, and parasites to stop antimicrobial drugs from working against them. The discovery of antimicrobials created new treatments but microbes developed resistance over time. Factors that contribute to resistance include overuse of antibiotics, lack of sanitation, and transmission of resistant genes between bacteria. Resistance occurs via natural and acquired mechanisms, the latter being a major clinical problem. Strategies to address resistance include prudent antibiotic use, developing new drugs, and alternative approaches like phage therapy.
Relative or complete lack of effect of antimicrobial agent against a previously susceptible microbe/pathogen.
It is an evolutionary principal that organism adopt genetically to change in their environment.
since the doubling time of bacteria can be as short as 20 mnt, there may be many generations in even a few hours, providing ample opportunity for evolutionary adaptation.
The phenomenon of resistance imposes serious constraints on the options available for the treatment of many bacterial infections.
The resistance to chemotherapeutic agents can also develop in protozoa, in multicellular parasites and in population of malignant cells.
Today there are different strains of S. aureus resistant to almost every form of antibiotic in use.
The document provides an overview of antibiotic resistance, including definitions of antibiotics and antibiotic resistance. It discusses mechanisms of antibiotic resistance such as enzyme modification, altered target sites, efflux pumps, and decreased membrane permeability. Causes of resistance include overuse and misuse of antibiotics in humans, agriculture, and health care settings. Management of resistance involves prudent antibiotic use, infection control, developing new antibiotics, and global cooperation. National action plans aim to combat resistance through improved awareness, surveillance, optimal antibiotic use, and investments in research.
Mechanism Antibiotic Resistance
Intrinsic (Natural)
Acquired
Chromosomal
Extra chromosomal
Intrinsic Resistance
Lack target : No cell wall; innately resistant to penicillin
2. Drug inactivation: Cephalosporinase in Klebsiella
3. Innate efflux pumps:
It is an active transport mechanism. It requires ATP.
Eg. E. coli, P. aeruginosa
Altered target sites
PBP alteration
Ribosomal target alteration
Decreased affinity by target modification
Beta-lactamase
Beta-lactamases are enzymes produced by bacteria that provide resistance to β-lactam antibiotics such as penicillins, cephamycins, and carbapenems
Major resistant Pathogen
1. PRSP- Penicillin resistant Streptococcus pneumoniae2. MRSA/ORSA- Methicillin-resistant Staphylococcus Aureus (Super bug)3. VRE -Vancomycin-Resistant Enterococci4. Carbapenem resistant pseudomonas aeruginosa5. Carbapenem resistant Carbapenem resistant 6. Extended spectrum beta-lactamase (ESBL)-producing bacteria
This document discusses antibiotic resistance, its causes like overuse of antibiotics and horizontal gene transfer between bacteria, and mechanisms like changing antibiotic structure or pumping it out of cells. It provides examples of diseases showing resistance like MRSA, tuberculosis, pneumonia and malaria. Possible solutions mentioned are vaccines, cytokines, bacteriophage therapy and responsible antibiotic use.
This document provides an overview of antibiotics, including their sources, classifications, mechanisms of action, and principles of antimicrobial therapy and selection. It focuses on penicillins as a class of antibiotics that act by inhibiting bacterial cell wall synthesis. Penicillins were discovered from the mold Penicillium and their basic structure consists of a beta-lactam ring. They work by inhibiting the bacterial enzyme DD-transpeptidase and preventing cell wall synthesis, ultimately causing bacterial cell lysis. Factors such as acid stability, spectrum of activity, and resistance are considered in developing different penicillin derivatives.
This document discusses antibiotic resistance and its mechanisms. It defines antibiotic resistance as bacteria developing the ability to resist antibiotics and continue growing. Resistance can be intrinsic or acquired. Intrinsic resistance is natural to the bacteria through impermeability, efflux pumps, biofilms, or enzymatic inactivation. Acquired resistance develops from mutations during antibiotic exposure or gene transfer, allowing target modification, new targets, or enzymatic inactivation. The document examines specific resistance mechanisms and notes the need to slow resistance by completing antibiotic treatments.
Antimicrobial resistance occurs when microorganisms develop the ability to defeat the drugs designed to treat them. There are natural and acquired forms of resistance. Natural resistance involves mechanisms like preventing drug entry or pumping it out, while acquired resistance occurs through mutation or horizontal gene transfer of resistance genes. These resistance genes can spread between bacteria through mobile genetic elements like plasmids, transforming many strains. As resistant bacteria infect more people, standard treatments become ineffective, necessitating new prevention and treatment approaches like bacteriophage therapy.
Antibiotic resistance occurs when bacteria evolve and adapt to antibiotics, making the drugs less effective at killing the bacteria. Many factors can contribute to the rise and spread of antibiotic resistance, including improper use of antibiotics in humans, agriculture, hospitals, and the environment. To address this growing problem, guidelines for antibiotic prescription and public awareness of appropriate antibiotic use need to be improved. Surveillance of antibiotic resistance patterns and infection control practices are also important for monitoring and containing the spread of resistant bacteria.
This document summarizes a seminar on antimicrobial resistance in Nepal. It discusses how antimicrobial resistance is a major public health issue as it can render treatments ineffective and allow infections to spread. It provides examples of resistant bacteria like MRSA. It then covers factors contributing to resistance like overuse of antibiotics in humans, animals, and the environment. The challenges of resistance in Nepal are outlined, such as poverty and lack of awareness. Finally, it proposes mitigation strategies including only using antibiotics when prescribed, reducing unnecessary use in animals, and addressing the issue in Nepal's public health system.
This document discusses antimicrobial resistance mechanisms. It covers natural resistance, acquired resistance, and various resistance mechanisms including biochemical mechanisms like reduced drug entry, efflux pumps, and drug inactivation. It also discusses mutation, gene transfer through transduction, transformation and conjugation, cross resistance, and strategies for preventing drug resistance like prudent antimicrobial use and combination therapy.
This document discusses antimicrobial resistance in Libya. It finds resistance is a serious problem that is increasing, including emerging resistance to newer drugs. Many bacteria isolated from clinical and other sources in Libya show high resistance percentages to various antibiotics. Resistance appears related to easy over-the-counter antibiotic access without prescription, improper hospital usage, and uncontrolled animal antibiotic use. Urgent action is needed to regulate antibiotic sales and usage, educate on proper clinical use, control hospital infections, and regulate non-human antibiotic use to address this growing resistance issue in Libya.
1) Antibacterial agents, also known as antibiotics, are used to inhibit bacterial growth or kill bacteria. They are commonly classified based on their chemical origin or biological effect.
2) Antibacterial agents work by targeting differences between bacterial and animal cells, interfering with bacterial cell wall synthesis, protein synthesis, nucleic acid synthesis, or folic acid synthesis.
3) Common mechanisms of resistance include enzymatic modification of the antibacterial agent, mutations that prevent binding, or active efflux of the agent from the bacterial cell.
This document provides an overview of antimicrobials (also known as antibiotics). It defines antimicrobials and discusses their classification as bactericidal or bacteriostatic. The document outlines the history of antimicrobial discovery and discusses their sources, selective toxicity, and modes of action. Key topics covered include the classification of antibiotics based on chemical structure and mechanism of action, as well as details on specific classes of antibiotics like penicillins, cephalosporins, carbapenems, and others.
This document discusses antimicrobial resistance, including its definition, causes, mechanisms, and impact. It notes that resistance arises naturally but is accelerated by misuse and overuse of antimicrobials in both humans and animals. Resistance occurs via several mechanisms including inactivating drugs, modifying drug targets in bacteria, exporting drugs from bacteria, reducing drug permeability, and mutating genes involved in drug mechanisms of action. It highlights several important antibiotic-resistant bacteria like MRSA, VRE, and multi-drug resistant TB. The global spread of resistance poses a major threat to modern medicine.
A 41-year-old woman with aplastic anemia was admitted with fever. Blood cultures grew E. coli resistant to ampicillin and narrow-spectrum cephalosporins. Despite treatment with multiple antimicrobials over 4 weeks, the patient's fever and bacteremia persisted. The microbiology lab was contacted to help determine why standard therapies were failing to clear the infection.
This document discusses antibiotic resistance mechanisms. It defines antimicrobial resistance (AMR) as when microbes become insensitive to medicines, making infections harder to treat. AMR occurs through two main mechanisms: acquired resistance, where bacteria gain resistance genes, usually through overuse of antibiotics creating selective pressure; and intrinsic resistance, where bacteria innately resist certain drug classes. Bacteria develop resistance via decreased permeability, efflux pumps, enzymatic inactivation of drugs like beta-lactamases, and modifying drug targets. Resistance can be transmitted between bacteria through mutation or mobile genetic elements like plasmids.
There are four main mechanisms by which bacteria become resistant to antibiotics: enzyme production, modified drug targets, decreased permeability, and multidrug resistance pumps. Resistance can be chromosome-mediated via mutations or plasmid-mediated via horizontal gene transfer, with plasmids frequently conferring resistance to multiple drugs. Overuse and misuse of antibiotics, both in medicine and agriculture, places strong selective pressure that drives the emergence and spread of resistant bacteria.
Mechanistic View of Antibiotic Resistance
1. Antibiotic resistance occurs when bacteria no longer respond to antibiotics designed to kill them, allowing them to continue growing. 2. Resistance can be intrinsic, through natural mechanisms like efflux pumps, or acquired through genetic mutations or transfer of genes. 3. Acquired resistance is a concern as it can lead to treatment failure, increased mortality, and spread in communities.
Drug resistance has increased significantly over the past decades as various resistance mechanisms have emerged and spread globally. The document discusses the history of drug resistance beginning with penicillin in the 1940s and the subsequent emergence of resistance to various classes of antibiotics. It describes several factors that have led to increased resistance such as inappropriate antibiotic use in medicine, agriculture, and genetically modified crops. Common resistance mechanisms involve production of antibiotic-modifying enzymes like beta-lactamases, altered antibiotic targets, decreased antibiotic permeability, and active efflux of antibiotics. Detection methods for various resistance enzymes and phenotypes like ESBLs and AmpC beta-lactamases are also summarized.
This document discusses antimicrobial resistance and provides definitions, history, and mechanisms. It defines antimicrobial resistance as the ability of microorganisms like bacteria, viruses, and parasites to stop antimicrobial drugs from working against them. The discovery of antimicrobials created new treatments but microbes developed resistance over time. Factors that contribute to resistance include overuse of antibiotics, lack of sanitation, and transmission of resistant genes between bacteria. Resistance occurs via natural and acquired mechanisms, the latter being a major clinical problem. Strategies to address resistance include prudent antibiotic use, developing new drugs, and alternative approaches like phage therapy.
Relative or complete lack of effect of antimicrobial agent against a previously susceptible microbe/pathogen.
It is an evolutionary principal that organism adopt genetically to change in their environment.
since the doubling time of bacteria can be as short as 20 mnt, there may be many generations in even a few hours, providing ample opportunity for evolutionary adaptation.
The phenomenon of resistance imposes serious constraints on the options available for the treatment of many bacterial infections.
The resistance to chemotherapeutic agents can also develop in protozoa, in multicellular parasites and in population of malignant cells.
Today there are different strains of S. aureus resistant to almost every form of antibiotic in use.
The document provides an overview of antibiotic resistance, including definitions of antibiotics and antibiotic resistance. It discusses mechanisms of antibiotic resistance such as enzyme modification, altered target sites, efflux pumps, and decreased membrane permeability. Causes of resistance include overuse and misuse of antibiotics in humans, agriculture, and health care settings. Management of resistance involves prudent antibiotic use, infection control, developing new antibiotics, and global cooperation. National action plans aim to combat resistance through improved awareness, surveillance, optimal antibiotic use, and investments in research.
Mechanism Antibiotic Resistance
Intrinsic (Natural)
Acquired
Chromosomal
Extra chromosomal
Intrinsic Resistance
Lack target : No cell wall; innately resistant to penicillin
2. Drug inactivation: Cephalosporinase in Klebsiella
3. Innate efflux pumps:
It is an active transport mechanism. It requires ATP.
Eg. E. coli, P. aeruginosa
Altered target sites
PBP alteration
Ribosomal target alteration
Decreased affinity by target modification
Beta-lactamase
Beta-lactamases are enzymes produced by bacteria that provide resistance to β-lactam antibiotics such as penicillins, cephamycins, and carbapenems
Major resistant Pathogen
1. PRSP- Penicillin resistant Streptococcus pneumoniae2. MRSA/ORSA- Methicillin-resistant Staphylococcus Aureus (Super bug)3. VRE -Vancomycin-Resistant Enterococci4. Carbapenem resistant pseudomonas aeruginosa5. Carbapenem resistant Carbapenem resistant 6. Extended spectrum beta-lactamase (ESBL)-producing bacteria
This document discusses antibiotic resistance, its causes like overuse of antibiotics and horizontal gene transfer between bacteria, and mechanisms like changing antibiotic structure or pumping it out of cells. It provides examples of diseases showing resistance like MRSA, tuberculosis, pneumonia and malaria. Possible solutions mentioned are vaccines, cytokines, bacteriophage therapy and responsible antibiotic use.
This document provides an overview of antibiotics, including their sources, classifications, mechanisms of action, and principles of antimicrobial therapy and selection. It focuses on penicillins as a class of antibiotics that act by inhibiting bacterial cell wall synthesis. Penicillins were discovered from the mold Penicillium and their basic structure consists of a beta-lactam ring. They work by inhibiting the bacterial enzyme DD-transpeptidase and preventing cell wall synthesis, ultimately causing bacterial cell lysis. Factors such as acid stability, spectrum of activity, and resistance are considered in developing different penicillin derivatives.
This document defines antimicrobials and antibiotics, and describes their features and mechanisms of action. It explains that most modern antibiotics are produced by soil microorganisms and should have selective toxicity. Antibiotics can be bacteriostatic, inhibiting bacterial growth, or bactericidal, killing bacteria. They can have narrow or broad spectra of activity. Combining antibiotics can result in synergistic or antagonistic effects. The document also discusses antimicrobial resistance mechanisms in bacteria, adverse effects of antibiotics, and methods for antimicrobial susceptibility testing including disc diffusion, dilution, and E-test.
This document provides an overview of antibiotics, including their classification, mechanisms of action, and common types. It discusses how antibiotics are classified based on their mechanism of action, spectrum of activity, and mode of action. The major classes covered include penicillins, cephalosporins, macrolides, aminoglycosides, fluoroquinolones, and tetracyclines. Specific antibiotics are given within each class with details on their indications, mechanisms, and side effects. Combination antibiotic therapy and developing antibiotic resistance are also summarized.
This document provides an overview of different classes of antibiotics, including their mechanisms of action, common uses, and side effects. It discusses penicillins, cephalosporins, carbapenems, monobactams, macrolides, ketolides, lincosamides, aminoglycosides, fluoroquinolones, and trimethoprim/sulfamethoxazole. It also covers topics like antibiotic resistance, combinations, ideal properties, and complications of antibiotic therapy.
This document provides an overview of antibiotics, including their classification, mechanisms of action, and common types. It discusses how antibiotics are classified based on their mechanism of action, spectrum of activity, and mode of action. The major classes covered include penicillins, cephalosporins, macrolides, aminoglycosides, fluoroquinolones, and tetracyclines. Specific antibiotics are given within each class with details on their indications, mechanisms, and side effects. Combination antibiotic therapy and developing antibiotic resistance are also summarized.
Unit II-Part A- Antibiotics Provided By Immam Ud Din.pptxyounasnee
This document provides an overview of antibiotics and antimicrobial therapy. It defines key terms like antibiotics, defines categories of antibiotics based on their spectrum, and discusses factors involved in selecting appropriate antimicrobial agents. The document also covers intrinsic and acquired antimicrobial resistance and provides a brief history of antibiotics prior to the introduction of penicillin.
The document discusses general principles of antimicrobial therapy and chemotherapy of infectious diseases. It covers topics such as the ideal properties of antimicrobial drugs, mechanisms of bacterial resistance, principles of antimicrobial selection and combination therapy. It also discusses appropriate and misuse of antimicrobial agents, highlighting the importance of judicious antibiotic use to prevent resistance.
This document discusses antibiotics, including their classification, mechanisms of action, uses, and side effects. It covers several classes of antibiotics such as penicillins, cephalosporins, and their generations. Antibiotics work by inhibiting bacterial cell wall synthesis, disrupting cellular membranes, or interfering with protein, nucleic acid, or folic acid synthesis. Their use requires consideration of the infecting organism, patient factors, and development of resistance. Combination antibiotic therapy can have additive, synergistic, or antagonistic effects.
Antibiotic resistance is a growing public health problem caused by the overuse and misuse of antibiotics. The document discusses the various mechanisms by which bacteria develop resistance, including intrinsic, acquired, and gene transfer-related resistance. It emphasizes the need for prudent antibiotic use to slow resistance, such as only using antibiotics when necessary, completing full treatment courses, and developing new drug classes. All healthcare providers, including physicians, pharmacists and microbiologists, must work together using treatment guidelines to optimize antibiotic prescribing and containment of resistance.
FLOW OF THE SEMINAR
1. Definition – antibiotic resistance, Multi-resistance, cross-resistance in antibiotics
2. Evolution of resistance
3. Impact of resistance
4. The scenario of resistance: Global, India
5. Factors causing resistance
6. Mechanisms of resistance: Intrinsic and Acquired
7. Acquired mechanism of resistance
8. Quorum sensing
9. Mechanism of resistance in commonly used antibiotics
10. Methods for determining the resistance
11. Strategies to contain resistance
12. Antibiotic stewardship
13. Role of Pharmacologist
14. Initiatives undertaken by India to control resistance
Bacterial resistance against antibiotics and it’s preventionWtar Dargalayi
Bacterial resistance to antibiotics is a growing problem caused by overuse and misuse of antibiotics. When bacteria are exposed to antibiotics, resistance can develop through mutations or by acquiring resistance genes from other bacteria. This makes treatments ineffective for infections that were previously treatable. To slow the development of resistance, it is important to only use antibiotics appropriately when needed, follow prescribed treatment plans fully, and prevent the spread of infections. Proper antibiotic stewardship among healthcare providers and the public can help ensure these drugs remain effective.
This document discusses antibiotics, including their definition, history, classification, mechanisms of action, uses, and complications. Antibiotics are medications that kill or inhibit the growth of bacteria and were first discovered by Alexander Fleming in 1928. They are classified based on their mechanism of action (inhibiting cell wall, protein, or nucleic acid synthesis), spectrum of activity (narrow or broad), and mode of action (bacteriostatic or bactericidal). While antibiotics have reduced mortality from bacterial infections, their overuse and misuse has led to increased antibiotic resistance in bacteria.
The document discusses the problem of antibiotic resistance and strategies to contain it. It provides background on antibiotic resistance, describing how it can occur intrinsically in bacteria or be acquired through mutations, plasmids, or gene transfer. Various mechanisms of resistance are outlined, including decreased permeability, efflux pumps, target modification, and antibiotic inactivation. The Indian scenario highlights specific resistance issues. NDM-1 carbapenemase is described as a major concern due to its ability to spread. Containment strategies include developing new antibiotics, judicious antibiotic use, and infection control.
Development and prevention of antibiotic resistanceZubayar Rahman
Antibiotic resistance develops through natural and acquired means. Naturally, bacteria can destroy drugs, change permeability or targets to become tolerant. Acquired resistance occurs through genetic changes like mutation, conjugation, transduction or transformation that allow resistance traits to spread. Rational antibiotic use and preventing misuse and overuse can slow resistance development. Individuals should only take antibiotics as prescribed, while policymakers regulate use and improve infection control, and health professionals prescribe appropriately and prevent infections.
This document summarizes how antibiotics work, how antibiotic resistance evolves, and how physicists can help address the growing problem of antibiotic resistance. It discusses how antibiotics target bacterial processes like cell wall synthesis and protein synthesis. It also describes simple models that link the molecular mechanisms of antibiotic action to whole-cell physiology and growth. The document outlines pathways to antibiotic resistance, and how resistance can emerge more quickly in drug gradients due to strong selection at the wave front of expanding bacterial populations. It concludes by discussing opportunities for physicists to better understand biofilm infections and help design strategies to avoid antibiotic resistance.
This document discusses control of microorganisms through antimicrobial agents. It defines chemotherapy and antimicrobials, and notes that antibiotics are a type of antimicrobial. It describes how antimicrobial drugs work by exploiting biochemical differences between microbes and humans. It discusses the spectrum of antibiotic activity, mechanisms of antimicrobial action including inhibition of cell wall synthesis and protein synthesis, and selection of antimicrobial agents based on the organism, site of infection, and patient factors. Mechanisms of resistance and factors promoting resistance are also summarized.
This document discusses antibiotics, including their definitions, classifications, mechanisms of action, and resistance. Antibiotics are substances produced by microorganisms that kill or inhibit the growth of other microorganisms. They are classified based on their mechanism of action (such as inhibiting cell wall synthesis or protein synthesis), spectrum of activity (narrow or broad), and mode of action (bacteriostatic or bactericidal). Antibiotic resistance can occur through several mechanisms such as bacteria producing enzymes to inactivate antibiotics or reducing permeability to drugs. Combining antibiotics can result in synergistic effects against certain organisms.
Intro to Antibacterial drugs (Final Draft).pptxAroobaAthar
This document provides an introduction to antibiotic therapy. It defines antibiotics and chemotherapy, and classifies antibiotics based on their mode of action and spectrum. It discusses the major types of antibiotics, including bacteriostatic and bactericidal agents, and narrow and broad spectrum antibiotics. The document also covers antibiotic resistance mechanisms, sources of antimicrobials, superinfections, and defines an antibiogram.
Similar to Antibiotic resistance,introduction, cause, mechanism and solution of Antibiotic resistance (20)
Topic on the introduction to the clinical pharmacy services. INTRODUCTION TO PHARMACY PRACTICE & CONCEPT OF CLINICAL PHARMACY add the fundamentals on Contribute significantly to patient care through obtaining the accurate medication histories from patients or other sources.
verifying medication histories obtained by other health care professionals.
To obtain the correct information on aspects of drug use.
Compare medication for best
Assess the rationale for drugs prescribed.
Assess patient medication compliance.
Screen for DRPs.
Document allergies, S/E and adverse drug reactions.
Assess the evidence of drug abuse.
Drug Therapy Monitoring
provided by a clinical pharmacist for specific patients to optimize drug therapy to achieve health outcomes.
Medication Order Review.
Adverse Drug Reaction Management.
Clinical Review.
Therapeutic Drug Monitoring.
Pharmacist Interventions
Social health program; role of world health organization in Indian national p...Dr. Sharad Chand
This topic explains the Social health program; the role of the world health organization in the Indian national program. This is useful for understanding the importance of social health and the role of WHO.
Role of pharmacist in prevention and control of pandemicDr. Sharad Chand
This document discusses the roles of pharmacists in preventing and controlling pandemics. It states that pharmacists from different practice settings, such as community pharmacies, hospitals, research, academia, and clinical roles, all contribute in various ways. Community pharmacists help ensure continuous medication supply and provide public education. Hospital pharmacists support healthcare teams and monitor drug safety. Research and academic pharmacists develop new treatments and educate the public. Clinical pharmacists conduct drug monitoring and educate the public and healthcare workers. Overall, the document argues that pharmacists from all areas of practice serve important frontline roles during pandemics.
Web of Science and Scopus: Understanding the indexing systemDr. Sharad Chand
In this article, Ii is explained about the Web of Science and Scopus indexing databases and their quality measures. This provides a basic insight into the selection of a good quality journal for publications.
Interaction & discussion on pharmacy practice, pharmacy practice Dr. Sharad Chand
This document discusses the roles and goals of good pharmacy practice. It outlines four main roles for pharmacists: 1) prepare and distribute medical products, 2) maintain professional performance, 3) contribute to healthcare system effectiveness and public health, and 4) provide effective medication therapy management. Some key responsibilities within these roles include ensuring safe and effective medicine use, health promotion, and improving patient outcomes. The document also lists several competencies and services pharmacists can provide, such as medication therapy management, patient counseling, and clinical research support. Overall, the goal of pharmacy practice is to optimize patient care and health through safe, evidence-based use of medicines.
The basic management of respiratory tract infection with symptomatic and antibiotic therapy. One can refer as the overview of RTI and common therapy ascertained
Case presentation on SLE with Pleural effusion (Soap format)Dr. Sharad Chand
A 35-year old female patient presented with easy fatiguability, cough, left chest pain, fever and breathlessness for 1 month. She has a history of SLE and was on topical hydrocortisone. Examination found reduced breath sounds and dullness on the left lung. Tests showed anemia, neutrophilia and left pleural effusion. She was diagnosed with SLE and pleural effusion and treated with antibiotics, steroids and transfusions. Her symptoms improved and she was discharged on medications including erythromycin and prednisolone to manage her conditions.
This document summarizes the clinical bedside management of epilepsy. It discusses diagnosing epilepsy based on recurrent seizures from an underlying chronic cause. It outlines evaluating patients through history, examination, and lab tests. For acute management, it describes placing patients on their side to prevent aspiration, avoiding placing objects in the mouth, providing oxygen, and treating any metabolic disorders. It also discusses long term management including treating underlying conditions, avoiding triggers, prophylactic medication or surgery, and addressing psychological issues. Finally, it lists several common anti-epileptic drugs, their dosages, side effects, and interactions to consider in treatment.
The information regarding the dengue fever, Introduction, epidemiology, aetiology, symptoms, general management and prevention , along with one example of the journal club.
Renal replacement therapy is used to remove waste and fluid when kidney function is severely impaired and life is at risk. There are four main forms: hemodialysis, hemofiltration, peritoneal dialysis, and hemodiafiltration. Hemodialysis involves removing blood from the body, passing it through a dialyzer to filter out waste and fluid before returning it. Hemofiltration is similar but uses convection rather than diffusion and does not require dialysate. Peritoneal dialysis infuses fluid into the abdomen to draw out waste. Hemodiafiltration combines hemodialysis and hemofiltration for enhanced waste and fluid control.
The patient counseling tool format along with the example of the case study, The important points that are to considered by the diabetic patients to prevent its complications.
Patient information leaflet (PIL)Tuberculosis By Sharad chand ( Pharm D Intern)Dr. Sharad Chand
The sample of PIL for beginers. It is the tool to help for better understanding by the patients and general population. It contains some basic information regarding the specific concern.
Seminar on neuralgia by sharad chand, Refer note for 4rth Pharm D studentsDr. Sharad Chand
This seminar discusses various types of neuralgia, including causes, symptoms, diagnosis, and treatment. Neuralgia is severe pain that follows the path of a nerve and can be caused by drug reactions, injuries, infections, tumors, or other issues that damage or irritate nerves. Trigeminal neuralgia is a severe facial pain disorder caused by compression of the trigeminal nerve. Post-herpetic neuralgia is nerve pain after a shingles outbreak. Glossopharyngeal neuralgia causes throat and ear pain from issues with the glossopharyngeal nerve. Treatment involves medications like anticonvulsants, antidepressants, or surgery if medications do not help. The seminar provides an overview of different neural
Journal club -pharmacist intervention in cost saving.Dr. Sharad Chand
The study evaluated the impact of a clinical pharmacist intervention in a nephrology unit between 2012 and 2013. The number of pharmacist interventions increased significantly from 824 in 2012 to 1977 in 2013. This resulted in estimated cost savings of $52,072 in 2012 and $144,138 in 2013. Estimated cost avoidance of preventable adverse drug events increased from $3,383,700 in 2012 to $7,342,200 in 2013. The benefit-cost ratio doubled from 4.29 to 9.36 after the pharmacist's involvement. Overall, the study demonstrated that a clinical pharmacist can reduce medication errors and healthcare costs while preventing adverse events.
Basic life support & basic medical procedureDr. Sharad Chand
This document provides information on various medical procedures. It begins by defining cardiopulmonary resuscitation (CPR) and its components of assessing airway, breathing, circulation, and obtaining emergency help. It then describes procedures for inserting a nasogastric tube, placing an intravenous cannula, performing abdominal paracentesis and thoracentesis, and intubating a patient. Risks and steps for each procedure are outlined. References on clinical medicine and life support are also listed.
This document discusses gene therapy, including what it is, how it works, and its applications and future possibilities. Gene therapy is a technique for correcting defective genes. It can be done by inserting a normal gene, substituting a gene, or repairing the original gene. Gene therapy has applications in treating liver storage diseases, hemoglobinopathies, cystic fibrosis, retinal pigmentation, cardiovascular issues like re-stenosis, and cancers. The document concludes that gene therapy offers the possibility of a healthy future.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
3. •What is Antibiotic Resistance?
•Causes
•Mechanisms of Resistance
•Examples of diseases that show resistance:
•Possible Solutions
Outline of Topic
4. •Cellular stress results in selective
pressures on a microorganism,
leading to the development of
resistance within a population
•Three possible outcomes when
antibiotics are introduced:
1. Death (Bacteriocidal)
2. Growth Inhibition (Bacteriostatic)
3. Resistance
•The ability of a microorganism to avoid the harmful effects of an
antibiotic by destroying it, transporting it out of the cell, or undergoing
changes that block its effects.
Antibiotic Resistance
5.
6. •Conjugation: Transfer of a plasmid
through direct cell contact. R Plasmids
confer resistance.
•Rolling circle:
Conjugation bridge is made
between cells
Plasmid begins to replicate as a
rolling circle
Travels across bridge in a linear
fashion
Recircularizes in recipient cell
•Horizontal gene transfer- Transfer of
genes without production of
offspring.
Bacterial Processes Leading to Resistance
7. Transformation: Uptake of
DNA from the environment,
incorporation into the
genome, and gene expression.
Transduction- The insertion
of genetic material from a
virus (Bacteriophage).
Vertical Gene Transfer:
Transfer of genetic material
from parent to daughter cell
(Generational Inheritance)
Bacterial Processes Leading to Resistance
8. •Although resistance is natural still
resistant bacteria multiply when
antibiotics are used carelessly.
•Millions of people take antibiotics
unnecessarily every year.
•Antibiotics have no effect on viral
illnesses such as:
Colds
Flu
Sore Throats
Bronchitis
•Use of antibiotics for feed animals
and livestock also a major factor.
Misuse/Overuse of Antibiotics
9. • Change the antibiotic
structure so that it is
no longer able to
perform its function
• Break down the
antibiotic
• Pump the antibiotic
out of the cell
Mechanisms of Resistance
10. •Methicillin-Resistant
Staphylococcus aureus
Also Vancomycin Resistant
(VRSA)
•Infects the nostrils, respiratory
tract, wounds, and urinary
tract.
•Commonly found and
contracted within hospitals and
healthcare centers
(Nosocomial Infection)
MRSA
11. •Mycobacterium tuberculosis
•Four antibiotics used: isoniazid,
rifampicin, pyrazinamide, and
ethambutol for 6 months.
•Most of them nihibit the synthesis of
mycolic acids, a major component of
the cell wall.
•Multi–drug-resistant tuberculosis is
resistant to two antibiotics,
Extensively drug resistant
tuberculosis is resistant to three, with
a cure rate of only 30%.
Tuberculosis
12. •Streptococcus pneumoniae and
Klebsiella pneumoniae (CRKP)
•Several strains of pneumonia
that is resistant to at least one
antibiotic.
•There are seven strains of
resistant pneumonia, the most
well known of which is the 19A
strain.
Pneumonia
13.
14. 1) Vaccines: manufacturing vaccines for
resistant strains of bacteria.
Don’t suffer the same fate as antibiotics, as
they stimulate the body’s immune system to
eradicate the infection.
2) Cytokines:
Several government organizations are
experimenting with adding cytokines to
animal feed rather than antibiotics.
Have been found to enhance the growth of
the animals, without the use of antibiotics.
Potential Solutions
15. 3) Bacteriopage therapy:
The therapeutic use of lytic bacteriophages to
treat bacterial infections.
4) Responsible use of antibiotics:
Only use when prescribed for a bacterial
infection.
Use exactly as instructed, do not stop
treatment early.
Research ways of making products safe while
reducing the use of antibiotics.
Potential Solutions
16. Potential Solutions
• To strengthen the action of antibiotics by modifying them so
the bacterial enzymes that cause resistance cannot attack them.
• Alternately, "decoy" molecules can be used along with the
antibiotic. Decoy molecules such as clavulanic acid or
sulbactam are already in use for blocking the beta-lactamase
enzymes that destroy the penicillin family of drugs.
• To interfere with the mechanisms that promote resistance. For
example, interfering with the duplication or movement of a
bacterium's genetic material would eliminate the transfer of
resistance genes between bacteria.
• Siderofore trozan molecule concept.